AlphaCrest Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-19,687
| Closed | -$1.4M | – | 159 |
|
|
2022
Q3 | $1.4M | Sell |
19,687
-152,044
| -89% | -$10.8M | 0.09% | 403 |
|
|
2022
Q2 | $13.2M | Buy |
171,731
+97,581
| +132% | +$7.51M | 0.64% | 4 |
|
|
2022
Q1 | $5.42M | Sell |
74,150
-117,170
| -61% | -$8.56M | 0.3% | 46 |
|
|
2021
Q4 | $11.9M | Sell |
191,320
-37,587
| -16% | -$2.34M | 0.44% | 18 |
|
|
2021
Q3 | $13.5M | Buy |
228,907
+142,613
| +165% | +$8.44M | 0.7% | 4 |
|
|
2021
Q2 | $5.77M | Sell |
86,294
-22,071
| -20% | -$1.47M | 0.25% | 81 |
|
|
2021
Q1 | $6.84M | Buy |
108,365
+32,414
| +43% | +$2.05M | 0.38% | 36 |
|
|
2020
Q4 | $4.71M | Buy |
75,951
+24,977
| +49% | +$1.55M | 0.39% | 37 |
|
|
2020
Q3 | $3.07M | Buy |
50,974
+29,707
| +140% | +$1.79M | 0.33% | 34 |
|
|
2020
Q2 | $1.25M | Sell |
21,267
-25,976
| -55% | -$1.53M | 0.21% | 105 |
|
|
2020
Q1 | $2.63M | Buy |
47,243
+31,612
| +202% | +$1.76M | 0.32% | 33 |
|
|
2019
Q4 | $1M | Sell |
15,631
-24,800
| -61% | -$1.59M | 0.08% | 346 |
|
|
2019
Q3 | $2.05M | Sell |
40,431
-124,312
| -75% | -$6.3M | 0.12% | 223 |
|
|
2019
Q2 | $7.47M | Buy |
164,743
+91,088
| +124% | +$4.13M | 0.65% | 4 |
|
|
2019
Q1 | $3.51M | Buy |
73,655
+48,055
| +188% | +$2.29M | 0.53% | 14 |
|
|
2018
Q4 | $1.33M | Buy |
+25,600
| New | +$1.33M | 0.4% | 29 |
|